Catherine Stamoulis

article 2026

93. Central sensitization, functional ability, and inflammatory markers in females with endometriosis and chronic pelvic pain

·doi:10.1016/j.jpag.2026.01.138

article 2025

14. Quantitative Sensory Testing in Females with Endometriosis and Chronic Pelvic Pain

·doi:10.1016/j.jpag.2025.01.027

article 2025

3. Cardiovascular Risk in Females with Endometriosis

·doi:10.1016/j.jpag.2025.01.015

article 2024

2. Depression in Adolescent and Adult Women with Endometriosis

·doi:10.1016/j.jpag.2024.01.147

article 2024

97. Pain Interference in Adolescents and Adults with Chronic Pelvic Pain Due to Endometriosis

·doi:10.1016/j.jpag.2024.01.104

article 2021

Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate

F&S reports ·doi:10.1016/j.xfre.2021.07.003

OBJECTIVE: To estimate the efficacy and safety of a novel nonhormonal therapeutic agent, cabergoline, compared with that of the standard clinical therapy, norethindrone acetate (NETA), for the treatment of endometriosis-associated pain in y…